#ASCEMBL - Twitter Hashtag

almost 3 years ago

Looking for a quick read 👓 and expert opinions on The ASCEMBL Trial? Try our article on updated results! 📰 By Dr. Aditi Sharma and @a_mangaonkar 🩸 https://t.co/k0fId3xf1d #Oncology #HematologicMalignancies #Hematology #ASCEMBL #CancerNews #CancerUpdates

0

3

0

395

C. HIRASE @HiraseMD

over 3 years ago

#ASCEMBL 試験に参加した日本人 #CML 患者16名のサブグループ解析に関する報告（Cancer Medicine 2023; 12: 2990-8） https://t.co/EVNwF117PF

0

1

0

269

A. Emre Eşkazan, MD 🩸🔬

@eskazanae

about 5 years ago

almost ready for my talk at the 8th International Congress on Leukemia Lymphoma Myeloma on new treatment options for chronic myeloid leukemia 🤓 #asciminib #ASCEMBL

eskazanae's tweet photo. almost ready for my talk at the 8th International Congress on Leukemia Lymphoma Myeloma on new treatment options for chronic myeloid leukemia 🤓
#asciminib
#ASCEMBL https://t.co/vtoLy1Cbfb

1

21

0

Naveen Pemmaraju, MD @doctorpemm

over 5 years ago

#ASH20 #LBA4 Dr A. Hochhaus Ph3 #ASCEMBL #Asciminib vs #Bosutinib in patients with #CML after 2 or more TKIs. #STAMP = Specifically Target the #ABL1 #Myristoyl Pocket | #leusm #mpnsm #BCRABL

doctorpemm's tweet photo. #ASH20 #LBA4 Dr A. Hochhaus Ph3 #ASCEMBL #Asciminib vs #Bosutinib in patients with #CML after 2 or more TKIs. #STAMP = Specifically Target the #ABL1 #Myristoyl Pocket | #leusm #mpnsm #BCRABL https://t.co/0q1zljCQLq

0

3

2

0

EmatoInfo @EmatoInfo

over 5 years ago

#ASH20 | #ASCEMBL: asciminib was nearly twice as effective as a SOC treatment regimen for patients who had recurrent chronic myeloid #leukemia despite two previous courses of TKIs. @AndreasHochhaus #leusm

EmatoInfo's tweet photo. #ASH20 | #ASCEMBL: asciminib was nearly twice as effective as a SOC treatment regimen for patients who had recurrent chronic myeloid #leukemia despite two previous courses of TKIs.

@AndreasHochhaus #leusm https://t.co/H3mCSXagem

0

10

3

0

Top Tweets for #ASCEMBL

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users